344296-05-5 Usage
Uses
Used in Pharmaceutical Research:
2-BROMO-6-METHOXY-3-NITRO-PYRIDINE is used as a building block in the synthesis of various biologically active molecules, contributing to the development of new pharmaceuticals with potential therapeutic applications.
Used in Agrochemical Production:
2-BROMO-6-METHOXY-3-NITRO-PYRIDINE is utilized as an intermediate in the production of agrochemicals, aiding in the creation of effective compounds for agricultural applications.
Used in Organic Synthesis:
2-BROMO-6-METHOXY-3-NITRO-PYRIDINE is employed as a key intermediate in organic synthesis, enabling the development of a wide range of chemical compounds with diverse applications.
Used in Fine Chemicals Production:
2-BROMO-6-METHOXY-3-NITRO-PYRIDINE is used as a valuable intermediate in the production of fine chemicals, contributing to the synthesis of high-quality specialty chemicals for various industries.
Safety Precautions:
It is important to handle and store 2-BROMO-6-METHOXY-3-NITRO-PYRIDINE with care due to its toxic nature. Exposure to 2-BROMO-6-METHOXY-3-NITRO-PYRIDINE may cause irritation to the respiratory system, skin, and eyes, necessitating proper safety measures during its use and storage.
Check Digit Verification of cas no
The CAS Registry Mumber 344296-05-5 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 3,4,4,2,9 and 6 respectively; the second part has 2 digits, 0 and 5 respectively.
Calculate Digit Verification of CAS Registry Number 344296-05:
(8*3)+(7*4)+(6*4)+(5*2)+(4*9)+(3*6)+(2*0)+(1*5)=145
145 % 10 = 5
So 344296-05-5 is a valid CAS Registry Number.
344296-05-5Relevant academic research and scientific papers
HETEROCYCLIC COMPOUNDS AND METHODS OF USE
-
Paragraph 000306, (2020/02/06)
The present invention discloses compounds useful in treatment of conditions associated with excessive activity of transforming growth factor beta (TGF-β), particularly type 1 or activin-like kinase 5 (ALK 5). Specifically the present invention discloses compound of formula (I) which exhibit inhibitory activity against ALK 5. Method of treating conditions associated with excessive activity (ALK 5) with such compound is disclosed. Uses thereof, pharmaceutical composition, and kits are also disclosed.
Substituent Effects on the Isomer Ratios in the Rearrangement of Some 2- and 4-Nitraminopyridines
Deady, Leslie W.,Korytsky, Olga L.,Rowe, Jeffrey E.
, p. 2025 - 2034 (2007/10/02)
The preparation, and rearrangement in 92percent sulfuric acid, of 4-X-2-nitramino- (1), 2-X-4-nitramino- (2), and 6-X-2-nitramino-pyridines (3) is reported (X=H,Me,MeO,Br,Cl,CO2H).The product isomer ratios can be explained by differential electronic stabilization of the appropriate ? complexes for aromatic nitration and steric effects seem relatively unimportant.Deuteration had no effect on the product distribution
